aTyr Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. aTyr Pharma's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 97% to $353,000. Profit margin reached -14275%. Total operating expenses were $55,272,000.
Profit Margin
| 2014 | 0 | -24.35M | |
|---|---|---|---|
| 2015 | 0 | -47.97M | |
| 2017 | 0 | -48.20M | |
| 2020 | 10.45M | -16.22M | -155.18% |
| 2023 | 353K | -50.38M | -14274.5% |
ATYR Income Statement (2014 – 2023)
| 2023 | 2020 | 2017 | 2015 | 2014 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 353K | 10.45M | 0 | 0 | 0 |
Cost of revenue | 2.74M | 17.29M | 713K | 0 | 0 |
Gross profit | -2.38M | -6.83M | -713K | 0 | 0 |
Operating exp. | |||||
Research and development | 42.29M | 17.29M | 30.06M | 34.50M | 16.77M |
Selling and marketing | 0 | -1.26M | 0 | 0 | 0 |
Total operating expenses | 55.27M | 25.1M | 46.43M | 47.61M | 23.55M |
Operating income | -54.91M | -15.91M | -47.14M | -47.61M | -23.55M |
Other income (expenses), net | 4.52M | -319K | -1.06M | -357K | -796K |
Income before tax | -50.39M | -16.23M | -48.20M | -47.97M | -24.35M |
Income tax expense | 0 | -6K | 0 | 0 | 0 |
Net income | -50.38M | -16.22M | -48.20M | -47.97M | -24.35M |
Earnings per share | |||||
Basic EPS | -0.94 | -1.77 | -26.16 | -42.42 | -422.73 |
Diluted EPS | -0.94 | -1.77 | -26.16 | -42.42 | -415.63 |